Skip to main content
. 2016 Nov 23;2016:3417976. doi: 10.1155/2016/3417976

Table 2.

Characteristics of studies of HBV infection and CCA risk.

Authors Year Country Cases (n) Controls (n) Control description Adjusted OR (95% CI) Study quality Reference
Lee et al. 2015 Korea 276 552 Hospital-based control 4.12
(2.01–8.44)
7 [32]
Zhou et al. 2014 China 126 504 Hospital-based control 19.245
(13.260–27.931)
7 [33]
Li et al. 2014 China 183 549 Hospital-based control NR 8 [34]
Chang et al. 2013 China (Taiwan) 5157 8716 Population-based control NR 9 [35]
Peng et al. 2011 China 98 196 Hospital-based control 2.75
(1.27–5.95)
8 [36]
Cai et al. 2011 China 313 608 Hospital-based control NR 7 [37]
Srivatanakul et al. 2010 Thailand 106 106 Population-based control NR 6 [38]
Zhou et al. 2010 China 317 634 Hospital-based control 9.669
(6.329–14.77)
8 [39]
Tao et al. 2010 China 190 380 Hospital-based control NR 8 [40]
Lee et al. 2009 China (Taiwan) 160 160 Hospital-based control 4.985
(2.775–8.945)
6 [41]
Zhou et al. 2008 China 312 438 Hospital-based control 8.876
(5.973–13.192)
6 [42]
Hsing et al. 2008 China 134 762 Population-based control NR 8 [43]
Lee et al. 2008 Korea 622 2488 Hospital-based control 2.3
(1.6–3.3)
7 [44]
Yamamoto et al. 2004 Japan 50 200 Hospital-based control NR 6 [45]

NR: not reported.